Unrecognized disease progression is associated with higher health care costs both for patients with end-stage kidney disease and late-stage (stages G4-G5) chronic kidney disease.
Jennifer St. Clair Russell, PhD, MSEd, MCHES
Advertisement
Articles by Jennifer St. Clair Russell, PhD, MSEd, MCHES
Advertisement
Latest Updated Articles
- Health Care Costs Associated With Unrecognized Progression to Late-Stage Kidney Disease
Published: February 16th 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Investigating the Role of Gut Microbiota in IPF
2
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
3
Behind the Scenes of Multiple Myeloma Care: A Pharmacist’s View With Kelley L. Julian, PharmD, BCOP
4
Cost, Access Barriers Limit Women’s Use of Heart Monitors: Lindsey Valenzuela, PharmD
5
